Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: bioengineering – Page 42

“O poplar tree, O poplar tree, how carbon-dense are thy branches …”

Trees are a major tool in our fight against climate change by sucking up carbon dioxide, but one company is taking them a step further: genetically engineering trees to sequester even more carbon. U.S. climate technology startup Living Carbon is developing genetically engineered seedlings of a hybrid poplar that it says can accumulate up to 53% more biomass than control plants and thereby absorb 27% more carbon.

Plants use sunlight to turn water and carbon dioxide into oxygen and sugar, a process known as photosynthesis. Living Carbon says its trees, a hybrid of the common aspen (Populus tremula) and white poplar (P. alba), can do it better with genetic changes to boost its photosynthetic performance.

Read more | >

The weaponization of the scientific and technological breakthroughs stemming from human genome research presents a serious global security challenge. Gene-editing pioneer and Nobel Laureate Jennifer Doudna often tells a story of a nightmare she once had. A colleague asked her to teach someone how her technology works. She went to meet the student and “was shocked to see Adolf Hitler, in the flesh.”

Doudna is not alone in being haunted by the power of science. Famously, having just returned home from Los Alamos in early 1945, John von Neumann awakened in panic. “What we are creating now is a monster whose influence is going to change history, provided there is any history left,” he stammered while straining to speak to his wife. He surmised, however, that “it would be impossible not to see it through, not only for military reasons, but it would also be unethical from the point of view of the scientists not to do what they knew is feasible, no matter what terrible consequences it may have.”

According to biographer Ananyo Bhattacharya, von Neumann saw what was happening in Nazi Germany and the USSR and believed that “the best he could do is allow politicians to make those [ethical and security] decisions: to put his brain in their hands.” Living through a devastating world war, the Manhattan Project polymath “had no trust left in human nature.”

Read more | >

“The new research program, led by Associate Professor Adeel Razi, from the Turner Institute for Brain and Mental Health, in collaboration with Melbourne start-up Cortical Labs, involves growing around 800,000 brain cells living in a dish, which are then “taught” to perform goal-directed tasks. Last year the brain cells’ ability to perform a simple tennis-like computer game, Pong, received global attention for the team’s research.”

Monash University-led research into growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning, has been awarded almost $600,000 AUD in the prestigious National Intelligence and Security Discovery Research Grants Program.

According to Associate Professor Razi, the research program’s work using lab-grown brain cells embedded onto silicon chips, “merges the fields of artificial intelligence and synthetic biology to create programmable biological computing platforms,” he said.

Read more | >

A team of ingenious bioengineers at Arizona State University (ASU) has harnessed the power of childhood nostalgia, unveiling a creative solution to a long-standing challenge in DNA origami research.

They’ve successfully employed a LEGO robotics kit to build an affordable, highly effective gradient mixer for purifying self-assembling DNA origami nanostructures. This innovative breakthrough, detailed in a paper published one PLOS ONE, promises to revolutionize how scientists approach DNA origami synthesis.

The creation of DNA origami structures is an intricate process, requiring precise purification of nanostructures. Traditionally, this purification step involved rate-zone centrifugation, relying on a costly piece of equipment called a gradient mixer. However, the maverick minds at ASU have demonstrated that even the iconic plastic bricks of LEGO can be repurposed for scientific advancement.

Read more | >

Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, in collaboration with researchers at the University of California Santa Barbara, today announced a drug discovery platform that enables precise control of the integrated stress response (ISR), a biological pathway that is activated by cells in response to a wide variety of pathological and aging-associated conditions.

A new publication, “Optogenetic control of the integrated stress response reveals proportional encoding and the stress memory landscape,” authored by company founders and featured on the cover of Cell Systems describes a technique that triggers the ISR virtually using light and demonstrates how the accumulation of stress over time shifts a cell’s reaction from adaptation to apoptosis (programmed cell death).

“In a very real way, our platform puts cells into a virtual reality, making them experience stress in the absence of physical stressors,” said Maxwell Wilson, Ph.D., a co-founder of Integrated Biosciences and Assistant Professor of Molecular, Cellular, and Developmental Biology at the University of California Santa Barbara.

Read more | >

What happens when humans begin combining biology with technology, harnessing the power to recode life itself.

What does the future of biotechnology look like? How will humans program biology to create organ farm technology and bio-robots. And what happens when companies begin investing in advanced bio-printing, artificial wombs, and cybernetic prosthetic limbs.

Other topic include: bioengineered food and farming, bio-printing in space, new age living bioarchitecture (eco concrete inspired by coral reefs), bioengineered bioluminescence, cyberpunks and biopunks who experiment underground — creating new age food and pets, the future of bionics, corporations owning bionic limbs, the multi-trillion dollar industry of bio-robots, and bioengineered humans with super powers (Neo-Humans).

As well as the future of biomedical engineering, biochemistry, and biodiversity.

Continue reading “Timelapse of Future BIOTECHNOLOGY” | >

Our gut microorganisms, collectively known as the gut microbiota, affect far more than digestion. Bacteria in our intestinal tracts influence brain activity — and even the likelihood of developing mental disorders. Decades of research have shown that a bacterially imbalanced gut can disrupt many systems in the human body, contributing to obesity, malnutrition and even cancer. In a study published May 10 in Nature, Stanford Medicine researchers and collaborators used an ingestible device to capture the diversity of microorganisms, viruses, proteins and bile in the small intestine.

The proof-of-concept results provide early evidence that there are more comprehensive ways to measure microbiota in the digestive system than current sampling methods — which mostly focus on stool — and shed new light on how resident gut microbes might contribute to human physiology and disease.

“This paper demonstrates a big leap forward in microbial detection and captures the living gut microbiota in a nutshell,” said co-senior author KC Huang, PhD, a professor of bioengineering and of microbiology and immunology, co-senior author with David Relman, MD, a professor of medicine and of microbiology and immunology. “Samples from current tools don’t fully represent what’s going on inside of us. But it’s all we’ve had — until now.”

Read more | >

For many people, when they hear China and genetic engineering in the same sentence, it is often synonymous with scandal, and gene-edited babies may spring to mind.

And, although it is true that nearly five years ago, researcher He Jiankui infamously claimed he had created the first ever gene-edited babies, before going to prison for three years, China has continued to pour a lot of money into genetic engineering research, and aims to become a global leader in the field.

“The accumulative amount of financing in the gene therapy field in China has exceeded $3.3 billion. Also, according to a Frost & Sullivan study, it is estimated that by 2025, gene therapy will reach a scale of nearly $17.89 billion in China,” said Fiona Gao, founding partner of Chinsiders.

Read more | >